section name header

Information ⬇

These organisms generally cause a spectrum of disease similar to that caused by other GNB, including pneumonia (particularly ventilator-associated), UTI (especially catheter-related), intravascular device-related infection, surgical-site infection, and abdominal infections.

Treatment: Infections Caused by Other Gram-Negative Enteric Pathogens

  • Significant antibiotic resistance among these organisms makes therapy challenging.
    • - Many of these organisms (e.g., Serratia, Providencia, Acinetobacter, Citrobacter, Enterobacter, Morganella) have a derepressible AmpC β-lactamase that results in resistance to third-generation cephalosporins, monobactams, and—in many cases—β-lactam/β-lactamase inhibitor combinations.
    • - Morganella and Providencia are inherently resistant to the polymyxins and tigecycline.
  • Carbapenems and amikacin are most reliably active, and fourth-generation cephalosporins are active provided the organism does not express an ESBL. Susceptibility testing is essential. Some isolates may retain susceptibility only to colistin and polymyxin B.

Outline ⬆

Section 7. Infectious Diseases